A judge has confirmed the liquidation plan for Metabolife International Inc. that features a $55.8 million global settlement with various creditors that have filed ephedra-related claims against the bankrupt supplement maker.

The settlement resolves 257 ephedra claims not covered by Metabolife's insurers. About $1.5 billion in ephedra claims were filed against the company, the company said in its liquidation plan.

Metabolife and its shareholders, including three of its owners, will provide $21.1 million to the settlement.

The rest of the contributing parties, including the debtor's insurers and retailers that sold Metabolife's ephedra products, will provide the remaining $34.7 million, according to the plan.